Skip to content

A STUDY ON HOMOEOPATHIC MANAGEMENT OF ALLERGIC COLD

A PROSPECTIVE CLINICAL STUDY OF ALLERGIC RHINITIS AND ITS HOMOEOPATHIC MANAGEMENT

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041644
Enrollment
104
Registered
2022-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Homoeopathic Medicine: According to the individulization which is more similar is selected and appropriate potency is prescribed. Follow ups would be watched & analyzed as per the crite

Sponsors

Dr Anand A Kulkarni
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects of all age groups and both sex. 2 Subjects irrespective of their occupation and socio-economic status will be selected. 3 Subjects diagnosed as cases of allergic rhinitis covering clinical features and h/o paroxysmal attack and showing raised Absolute Eosinophil Count ie more than 440cells/cmm and more than 3 eosinophils in nasal secretion. 4 Subjects who have given consent for the study

Exclusion criteria

Exclusion criteria: 1 Subjects with any other chronic diseases and on active treatment. 2 Subjects with any anatomical or pathological irreversible structural changes. 3 Complications of allergic rhinitis like sinusitis, nasal polypi, serous otitis media, orthodontic problems, bronchial asthma

Design outcomes

Primary

MeasureTime frame
The progress of the treatment of patient shall be assessed as per the guidelines given in the Organon for each individual class of case. Recovered: Disappearance of all the presenting complaints that formed the portrait of the disease and normal level of eosinophil count i.e. less than 440 cells/cmm and no eosinophil seen in nasal secretion along with general well-being of the patient. Improved: Partial relief of some of the presenting complaints that formed the portrait of the disease with / without relief of clinical features of allergic rhinitis but relapsing of signs and symptoms, decreased in eosinophil count but not restore to normal i.e. more than 440 cells/cmm and eosinophils seen in nasal secretion general well-being of the patient. Not Improved: No relief from symptoms and no changes in Absolute Eosinophil Count in both blood and nasal secretion even after sufficient period of treatment, whatsoever. Timepoint: 12 months

Secondary

MeasureTime frame
The progress of the treatment of patient shall be assessed as per the guidelines given in the Organon for each individual class of case. Recovered: Disappearance of all the presenting complaints that formed the portrait of the disease and normal level of eosinophil count i.e. less than 440 cells/cmm and no eosinophil seen in nasal secretion along with general well-being of the patient. Improved: Partial relief of some of the presenting complaints that formed the portrait of the disease with / without relief of clinical features of allergic rhinitis but relapsing of signs and symptoms, decreased in eosinophil count but not restore to normal i.e. more than 440 cells/cmm and eosinophils seen in nasal secretion general well-being of the patient. Not Improved: No relief from symptoms and no changes in Absolute Eosinophil Count in both blood and nasal secretion even after sufficient period of treatment, whatsoever. Timepoint: 24 months

Countries

India

Contacts

Public ContactDr Dharmendra B Sharma

Dr D Y Patil Homoeopathic Medical college and Hospital Pimpri Pune

info.homoeopathy@dypvp.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026